-
1
-
-
0023597478
-
Pulmonary embolism and thrombophlebitis in the United States, 1970-1985
-
Gillum RF (1987) Pulmonary embolism and thrombophlebitis in the United States, 1970-1985. Am Heart J 114: 1262-1264.
-
(1987)
Am Heart J
, vol.114
, pp. 1262-1264
-
-
Gillum, R.F.1
-
2
-
-
35748983238
-
Estimated annual numbers of US acute-care hospital patients at risk for venous thromboembolism
-
Anderson FA, Zayaruzny M, Heit JA, Fidan D, Cohen AT (2007) Estimated annual numbers of US acute-care hospital patients at risk for venous thromboembolism. Am J Hematol 82: 777-782. doi:10.1002/ajh.20983.
-
(2007)
Am J Hematol
, vol.82
, pp. 777-782
-
-
Anderson, F.A.1
Zayaruzny, M.2
Heit, J.A.3
Fidan, D.4
Cohen, A.T.5
-
3
-
-
35048860791
-
Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality
-
Cohen AT, Agnelli G, Anderson FA, Arcelus JI, Bergqvist D, et al. (2007) Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb Haemost 98: 756-764.
-
(2007)
Thromb Haemost
, vol.98
, pp. 756-764
-
-
Cohen, A.T.1
Agnelli, G.2
Anderson, F.A.3
Arcelus, J.I.4
Bergqvist, D.5
-
4
-
-
0037111563
-
Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis
-
Prandoni P, Lensing AWA, Piccioli A, Bernardi E, Simioni P, et al. (2002) Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood 100: 3484-3488. doi:10.1182/blood-2002-01-0108.
-
(2002)
Blood
, vol.100
, pp. 3484-3488
-
-
Prandoni, P.1
Lensing, A.W.A.2
Piccioli, A.3
Bernardi, E.4
Simioni, P.5
-
5
-
-
0030317948
-
The long-term clinical course of acute deep venous thrombosis
-
Prandoni P, Lensing AW, Cogo A, Cuppini S, Villalta S, et al. (1996) The long-term clinical course of acute deep venous thrombosis. Ann Intern Med 125: 1-7.
-
(1996)
Ann Intern Med
, vol.125
, pp. 1-7
-
-
Prandoni, P.1
Lensing, A.W.2
Cogo, A.3
Cuppini, S.4
Villalta, S.5
-
6
-
-
0037054040
-
Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: A population-based study
-
Heit JA, O'Fallon WM, Petterson TM, Lohse CM, Silverstein MD, et al. (2002) Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study. Arch Intern Med 162: 1245-1248.
-
(2002)
Arch Intern Med
, vol.162
, pp. 1245-1248
-
-
Heit, J.A.1
O'Fallon, W.M.2
Petterson, T.M.3
Lohse, C.M.4
Silverstein, M.D.5
-
7
-
-
0032559947
-
The risk of a diagnosis of cancer after primary deep venous thrombosis or pulmonary embolism
-
Sorensen HT, Mellemkjaer L, Steffensen FH, Olsen JH, Nielsen GL (1998) The risk of a diagnosis of cancer after primary deep venous thrombosis or pulmonary embolism. N Engl J Med 338: 1169-1173. doi:10.1056/NEJM199804233381701.
-
(1998)
N Engl J Med
, vol.338
, pp. 1169-1173
-
-
Sorensen, H.T.1
Mellemkjaer, L.2
Steffensen, F.H.3
Olsen, J.H.4
Nielsen, G.L.5
-
8
-
-
0032507491
-
Venous thromboembolism and cancer
-
Baron JA, Gridley G, Weiderpass E, Nyrén O, Linet M (1998) Venous thromboembolism and cancer. Lancet 351: 1077-1080. doi:10.1016/S0140-6736(97)10018-6.
-
(1998)
Lancet
, vol.351
, pp. 1077-1080
-
-
Baron, J.A.1
Gridley, G.2
Weiderpass, E.3
Nyrén, O.4
Linet, M.5
-
9
-
-
79951674716
-
Risk of recurrent venous thromboembolism according to malignancy characteristics in patients with cancer-associated thrombosis: A systematic review of observational and intervention studies
-
Louzada ML, Majeed H, Dao V, Wells PS (2011) Risk of recurrent venous thromboembolism according to malignancy characteristics in patients with cancer-associated thrombosis: a systematic review of observational and intervention studies. Blood Coagul Fibrinolysis 22: 86-91. doi:10.1097/MBC.0b013e328341f030.
-
(2011)
Blood Coagul Fibrinolysis
, vol.22
, pp. 86-91
-
-
Louzada, M.L.1
Majeed, H.2
Dao, V.3
Wells, P.S.4
-
10
-
-
0034700438
-
Prognosis of cancers associated with venous thromboembolism
-
Sorensen HT, Mellemkjaer L, Olsen JH, Baron JA (2000) Prognosis of cancers associated with venous thromboembolism. N Engl J Med 343: 1846-1850. doi:10.1056/NEJM200012213432504.
-
(2000)
N Engl J Med
, vol.343
, pp. 1846-1850
-
-
Sorensen, H.T.1
Mellemkjaer, L.2
Olsen, J.H.3
Baron, J.A.4
-
11
-
-
84904726817
-
A prospective study on survival in cancer patients with and without venous thromboembolism
-
Agnelli G, Verso M, Mandalà M, Gallus S, Cimminiello C, et al. (2013) A prospective study on survival in cancer patients with and without venous thromboembolism. Intern Emerg Med. doi:10.1007/s11739-013-0985-z.
-
(2013)
Intern Emerg Med
-
-
Agnelli, G.1
Verso, M.2
Mandalà, M.3
Gallus, S.4
Cimminiello, C.5
-
12
-
-
77950794328
-
Treatment and secondary prevention of venous thromboembolism in cancer
-
Coleman R, MacCallum P (2010) Treatment and secondary prevention of venous thromboembolism in cancer. Br J Cancer 102 Suppl: S17-23. doi:10.1038/sj.bjc.6605601.
-
(2010)
Br J Cancer
, vol.102
, pp. S17-S23
-
-
Coleman, R.1
MacCallum, P.2
-
13
-
-
84888400659
-
Vitamin K antagonists in heart disease: Current status and perspectives (Section III). Position paper of the ESC Working Group on Thrombosis - Task Force on Anticoagulants in Heart Disease
-
De Caterina R, Husted S, Wallentin L, Andreotti F, Arnesen H, et al. (2013) Vitamin K antagonists in heart disease: current status and perspectives (Section III). Position paper of the ESC Working Group on Thrombosis - Task Force on Anticoagulants in Heart Disease. Thromb Haemost 110: 1087-1107. doi:10.1160/TH13-06-0443.
-
(2013)
Thromb Haemost
, vol.110
, pp. 1087-1107
-
-
De Caterina, R.1
Husted, S.2
Wallentin, L.3
Andreotti, F.4
Arnesen, H.5
-
14
-
-
84888415701
-
Cessation of oral anticoagulation in relation to mortality and the risk of thrombotic events in patients with atrial fibrillation
-
Gallego P, Roldan V, Marín F, Romera M, Valdés M, et al. (2013) Cessation of oral anticoagulation in relation to mortality and the risk of thrombotic events in patients with atrial fibrillation. Thromb Haemost 110: 1189-1198. doi:10.1160/TH13-07-0556.
-
(2013)
Thromb Haemost
, vol.110
, pp. 1189-1198
-
-
Gallego, P.1
Roldan, V.2
Marín, F.3
Romera, M.4
Valdés, M.5
-
15
-
-
84856802635
-
Antithrombotic therapy for VTE disease: Antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines
-
Kearon C, Akl EA, Comerota AJ, Prandoni P, Bounameaux H, et al. (2012) Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141: e419S-94S. doi:10.1378/chest.11-2301.
-
(2012)
Chest
, vol.141
, pp. e419S-e494S
-
-
Kearon, C.1
Akl, E.A.2
Comerota, A.J.3
Prandoni, P.4
Bounameaux, H.5
-
16
-
-
0037775584
-
Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer
-
Lee AYY, Levine MN, Baker RI, Bowden C, Kakkar AK, et al. (2003) Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. N Engl J Med 349: 146-153. doi:10.1056/NEJMoa025313.
-
(2003)
N Engl J Med
, vol.349
, pp. 146-153
-
-
Lee, A.Y.Y.1
Levine, M.N.2
Baker, R.I.3
Bowden, C.4
Kakkar, A.K.5
-
17
-
-
84899729145
-
Non-vitamin K antagonist oral anticoagulants (NOACs): No longer new or novel
-
Husted S, De Caterina R, Andreotti F, Arnesen H, Bachmann F, et al. (2014) Non-vitamin K antagonist oral anticoagulants (NOACs): No longer new or novel. Thromb Haemost 111. doi:10.1160/TH14-03-0228.
-
(2014)
Thromb Haemost
, vol.111
-
-
Husted, S.1
De Caterina, R.2
Andreotti, F.3
Arnesen, H.4
Bachmann, F.5
-
18
-
-
71849117615
-
Dabigatran versus warfarin in the treatment of acute venous thromboembolism
-
Schulman S, Kearon C, Kakkar AK, Mismetti P, Schellong S, et al. (2009) Dabigatran versus warfarin in the treatment of acute venous thromboembolism. N Engl J Med 361: 2342-2352. doi:10.1056/NEJMoa0906598.
-
(2009)
N Engl J Med
, vol.361
, pp. 2342-2352
-
-
Schulman, S.1
Kearon, C.2
Kakkar, A.K.3
Mismetti, P.4
Schellong, S.5
-
19
-
-
78650619315
-
Oral rivaroxaban for symptomatic venous thromboembolism
-
Bauersachs R, Berkowitz SD, Brenner B, Buller HR, Decousus H, et al. (2010) Oral rivaroxaban for symptomatic venous thromboembolism. N Engl J Med 363: 2499-2510. doi:10.1056/NEJMoa1007903.
-
(2010)
N Engl J Med
, vol.363
, pp. 2499-2510
-
-
Bauersachs, R.1
Berkowitz, S.D.2
Brenner, B.3
Buller, H.R.4
Decousus, H.5
-
20
-
-
84859385808
-
Oral rivaroxaban for the treatment of symptomatic pulmonary embolism
-
Büller HR, Prins MH, Lensin AWA, Decousus H, Jacobson BF, et al. (2012) Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. N Engl J Med 366: 1287-1297. doi:10.1056/NEJMoa1113572.
-
(2012)
N Engl J Med
, vol.366
, pp. 1287-1297
-
-
Büller, H.R.1
Prins, M.H.2
Lensin, A.W.A.3
Decousus, H.4
Jacobson, B.F.5
-
21
-
-
84885618705
-
Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism
-
Büller HR, Décousus H, Grosso MA, Mercuri M, Middeldorp S, et al. (2013) Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism. N Engl J Med 369: 1406-1415. doi:10.1056/NEJMoa1306638.
-
(2013)
N Engl J Med
, vol.369
, pp. 1406-1415
-
-
Büller, H.R.1
Décousus, H.2
Grosso, M.A.3
Mercuri, M.4
Middeldorp, S.5
-
22
-
-
84880327613
-
Oral apixaban for the treatment of acute venous thromboembolism
-
Agnelli G, Buller HR, Cohen A, Curto M, Gallus AS, et al. (2013) Oral apixaban for the treatment of acute venous thromboembolism. N Engl J Med 369: 799-808. doi:10.1056/NEJMoa1302507.
-
(2013)
N Engl J Med
, vol.369
, pp. 799-808
-
-
Agnelli, G.1
Buller, H.R.2
Cohen, A.3
Curto, M.4
Gallus, A.S.5
-
23
-
-
84925548115
-
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
-
Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol 62: 1006-1012. doi:10.1016/j.jclinepi.2009.06.005.
-
(2009)
J Clin Epidemiol
, vol.62
, pp. 1006-1012
-
-
Moher, D.1
Liberati, A.2
Tetzlaff, J.3
Altman, D.G.4
-
24
-
-
68549101842
-
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: Explanation and elaboration
-
Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, et al. (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 339: b2700.
-
BMJ
, vol.339
-
-
Liberati, A.1
Altman, D.G.2
Tetzlaff, J.3
Mulrow, C.4
Gotzsche, P.C.5
-
26
-
-
0022992740
-
Meta-analysis in clinical trials
-
DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177-188. doi:10.1016/0197-2456(86)90046-2.
-
(1986)
Control Clin Trials
, vol.7
, pp. 177-188
-
-
DerSimonian, R.1
Laird, N.2
-
27
-
-
23044505564
-
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients
-
Schulman S, Kearon C (2005) Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost 3: 692-694. doi:10.1111/j.1538-7836.2005.01204.x.
-
(2005)
J Thromb Haemost
, vol.3
, pp. 692-694
-
-
Schulman, S.1
Kearon, C.2
-
28
-
-
0037775584
-
Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer
-
Lee AYY, Levine MN, Baker RI, Bowden C, Kakkar AK, et al. (2003) Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. N Engl J Med 349: 146-153. doi:10.1056/NEJMoa025313.
-
(2003)
N Engl J Med
, vol.349
, pp. 146-153
-
-
Lee, A.Y.Y.1
Levine, M.N.2
Baker, R.I.3
Bowden, C.4
Kakkar, A.K.5
-
29
-
-
33846023633
-
Long-term low-molecular-weight heparin versus usual care in proximal-vein thrombosis patients with cancer
-
Hull RD, Pineo GF, Brant RF, Mah AF, Burke N, et al. (2006) Long-term low-molecular-weight heparin versus usual care in proximal-vein thrombosis patients with cancer. Am J Med 119: 1062-1072. doi:10.1016/j.amjmed.2006.02.022.
-
(2006)
Am J Med
, vol.119
, pp. 1062-1072
-
-
Hull, R.D.1
Pineo, G.F.2
Brant, R.F.3
Mah, A.F.4
Burke, N.5
-
30
-
-
33748498896
-
Secondary prevention of venous thromboembolic events in patients with active cancer: Enoxaparin alone versus initial enoxaparin followed by warfarin for a 180-day period
-
Deitcher SR, Kessler CM, Merli G, Rigas JR, Lyons RM, et al. (2006) Secondary prevention of venous thromboembolic events in patients with active cancer: enoxaparin alone versus initial enoxaparin followed by warfarin for a 180-day period. Clin Appl Thromb Hemost 12: 389-396. doi:10.1177/1076029606293692.
-
(2006)
Clin Appl Thromb Hemost
, vol.12
, pp. 389-396
-
-
Deitcher, S.R.1
Kessler, C.M.2
Merli, G.3
Rigas, J.R.4
Lyons, R.M.5
-
31
-
-
0037067889
-
Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer
-
Meyer G, Marjanovic Z, Valcke J, Lorcerie B, Gruel Y, et al. (2002) Comparison of Low-Molecular-Weight Heparin and Warfarin for the Secondary Prevention of Venous Thromboembolism in Patients With Cancer. Arch Intern Med 162: 1729. doi:10.1001/archinte.162.15.1729.
-
(2002)
Arch Intern Med
, vol.162
, pp. 1729
-
-
Meyer, G.1
Marjanovic, Z.2
Valcke, J.3
Lorcerie, B.4
Gruel, Y.5
-
32
-
-
42949091529
-
Anticoagulation for the long term treatment of venous thromboembolism in patients with cancer
-
Akl EA, Barba M, Rohilla S, Terrenato I, Sperati F, et al. (2008) Anticoagulation for the long term treatment of venous thromboembolism in patients with cancer. Cochrane database Syst Rev: CD006650. doi:10.1002/14651858.CD006650.pub2.
-
(2008)
Cochran database Syst Rev
, pp. CD006650
-
-
Akl, E.A.1
Barba, M.2
Rohilla, S.3
Terrenato, I.4
Sperati, F.5
|